T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma

Histone deacetylase inhibitors (HDACi) are active agents for peripheral T-cell lymphoma (PTCL). Anecdotally angioimmunoblastic T-cell lymphoma (AITL) appears to respond better than PTCL–not otherwise specified (NOS) to HDACi. The new World Health Organization classification shows that a subgroup of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Ghione, Paola, Faruque, Promie, Mehta-Shah, Neha, Seshan, Venkatraman, Ozkaya, Neval, Bhaskar, Shakthi, Yeung, James, Spinner, Michael A., Lunning, Matthew, Inghirami, Giorgio, Moskowitz, Alison, Galasso, Natasha, Ganesan, Nivetha, van der Weyden, Carrie, Ruan, Jia, Prince, H. Miles, Trotman, Judith, Advani, Ranjana, Dogan, Ahmet, Horwitz, Steven
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7556143/
https://ncbi.nlm.nih.gov/pubmed/33002132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002396
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars